Fused heteroaryl derivatives

Details Fused heteroaryl derivatives Fused heteroaryl derivatives

2010-01-15

2011-11-29

Chandrakumar, Nizal (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Chalcogen in the nitrogen containing substituent

Reexamination Certificate

active

08067586

ABSTRACT:
The present invention provides a pharmaceutical composition which is useful as a phosphatidylinositol 3 kinase (PI3K) inhibitor and an antitumor agent, and it provides a novel bicyclic or tricyclic fused heteroaryl derivative or a salt thereof which possesses an excellent PI3K inhibiting activity and cancer cell growth inhibiting activity.

REFERENCES:
patent: 3661908 (1972-05-01), Woitun et al.
patent: 3763156 (1973-10-01), Woitun et al.
patent: 3808211 (1974-04-01), Benjamin
patent: 3830813 (1974-08-01), Woitun et al.
patent: 3907799 (1975-09-01), O'Brien et al.
patent: 4007187 (1977-02-01), Fauran et al.
patent: 4146716 (1979-03-01), Cox et al.
patent: 4196207 (1980-04-01), Webber
patent: 4306065 (1981-12-01), Chen
patent: 5304554 (1994-04-01), Strekowski et al.
patent: 5444062 (1995-08-01), Coe et al.
patent: 5990117 (1999-11-01), Pamukcu et al.
patent: 6271225 (2001-08-01), Seio et al.
patent: 6420391 (2002-07-01), Konishi et al.
patent: 6518277 (2003-02-01), Sadhu et al.
patent: 6608056 (2003-08-01), Hayakawa et al.
patent: 6610698 (2003-08-01), Spohr et al.
patent: 6838457 (2005-01-01), Hayakawa et al.
patent: 2005/0014771 (2005-01-01), Hayakawa et al.
patent: 2 039 663 (1972-02-01), None
patent: 0 276 057 (1988-07-01), None
patent: 0 655 456 (1995-05-01), None
patent: 0 882 717 (1998-12-01), None
patent: 1 067 123 (2001-01-01), None
patent: 2 295 387 (1996-05-01), None
patent: 58-172379 (1983-10-01), None
patent: 10-87492 (1988-04-01), None
patent: 10-175977 (1998-06-01), None
patent: 11-209287 (1999-08-01), None
patent: WO 98/23613 (1998-06-01), None
patent: WO 99/43682 (1999-09-01), None
patent: WO 01/81346 (2001-11-01), None
Abdel-Hamide, CAPLUS Abstract 132:151765, 1999.
Berrie, PubMed Abstract (Expert Opin. Investig. Drugs 10(6): 1085-98), 2001.
Bi, et al., “Proliferative defect and embryonic lethality [..]”, J. Biol. Chem., 274, 10963-8 (1999).
Burguignon, et al., CAPLUS Abstract 83: 114329, 1975.
Di Cristofano, et al., “Pten is essential for embryonic development and tumor suppression”, Nature Genetics, col. 19, pp. 348-355 (1998).
Maehama, et al., “The Tumor Suppressor[. . .]”, J. Biol. Chem., 273, 13375-78, (1998).
Merino, et al., “Synthesis and Anti-HIV-1 activities of new pyrimido[5,4,-b]indoles”, vol. 54, No. 4., pp. 255-264 (1999).
Misawa, et al., PubMed Abstract (Biochem. Biophys. Res. Commun. 244(2):531-9), 1998.
Mokrosz, et al., CAPLUS Abstract 126 :126498, 1997.
Nishigaki, et al., “Synthetic Antibacterials. Nitrofurylvinylpyrido[2,3-d]pyrimidine derivatives”, J. Med. Chem., vol. 15, No. 7, pp. 731-734, 1972.
Osselaere, et al., Chemical Abstract 83 :9970n, 1975.
Peinador, et al., A convenient synthesis for some new pyrido[3′2′ :4,5]thieno-[3,2-d]pyrimidine derivativ es with potential biological activity,J. Heterocycl. Chem., 29(7) (1992), pp. 1693-1702 , Abstract.
Sangapure, et al., Chemical Abstract 134 :207777 (Indian Journal of Heterocyclic Chemistry, 10(1), pp. 21-26), 2000.
Simone, Oncology : Introduction, Cecil Textbook of Medicine, 20th Edition, vol. 1 , pp. 1004-1010, 1996.
Shioi, et al., “The conserved phosphoinositide 3-kinase pathway determines heart size in mice”, EMBO J., 19, 2537-48 (2000).
Tsizin, et al., “Synthesis and Antimicrobial Action of N-substituted—Hydroxyquinazolines”, vol. 7, No. 7, pp. 16-19 (1972).
Vaidya, et al. “Studies in Benzofurans: Part XII—Synthesis & Reactions . . . pyrimidine”, In. J. Chem., vol. 20B, No. 9, pp. 780-783 (1981).

Affiliated with

Also associated with

Rating

Fused heteroaryl derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused heteroaryl derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused heteroaryl derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4287369